Restoration of cellular function of mesenchymal stem cells from a hypophosphatasia patient.
Mesenchymal stem cells (MSCs) can differentiate into multiple cell lineages and are used for regenerative treatments for a variety of diseases. However, the patient's cells cannot be used to treat genetic diseases. Allogeneic cells can serve as an alternative but long-term survival is uncertain. Our experience of allo-transplantation to a patient with hypophosphatasia, which is caused by mutations of the tissue non-specific alkaline phosphatase (TNSALP) gene resulting in low serum alkaline phosphatase (ALP) activity and skeletal deformity, did not improve these clinical characteristics. Therefore, we sought to use autologous MSCs for the treatment of hypophosphatasia. MSCs derived from the patient's bone marrow had a similar profile when compared with well-reported MSCs. However, the MSCs had extremely low ALP activity and could not produce a mineralized bone matrix even under the osteogenic culture conditions. We therefore transduced a retroviral vector with TNSALP promoter-driven TNSALP gene in the MSCs. In the culture condition, the MSCs had about 7-fold higher ALP activity than did mock-transduced MSCs, and showed mineralization as well as bone-specific markers. Furthermore, the MSCs, but not mock-transduced MSCs, newly formed bone at the frequency of 50% in nude rats. Transplantation of the TNSALP-transduced autologous MSCs might become a new therapy for hypophosphatasia.
Katsube
Y
Y
Research Institute for Cell Engineering (RICE), National Institute of Advanced Industrial Science and Technology (AIST), Amagasaki, Hyogo, Japan.
Kotobuki
N
N
Tadokoro
M
M
Kanai
R
R
Taketani
T
T
Yamaguchi
S
S
Ohgushi
H
H
D000469:Alkaline Phosphatase / Q000097:blood / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D001483:Base Sequence; D002454:Cell Differentiation / Q000502:physiology; D017931:DNA Primers / Q000235:genetics; D005260:Female; D005434:Flow Cytometry; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D007014:Hypophosphatasia / Q000235:genetics* / Q000628:therapy*; D007223:Infant; D059630:Mesenchymal Stem Cells / Q000378:metabolism*; D008969:Molecular Sequence Data; D010012:Osteogenesis / Q000235:genetics / Q000502:physiology*; D051381:Rats; D011923:Rats, Nude; D012190:Retroviridae; D020133:Reverse Transcriptase Polymerase Chain Reaction; D017422:Sequence Analysis, DNA; D033581:Stem Cell Transplantation / Q000379:methods*; D014161:Transduction, Genetic
D017931:DNA Primers; C548267:ALPL protein, human; D000469:Alkaline Phosphatase